SLITRK6 References

SLITRK6
Identifiers
Aliases	SLITRK6, DFNMYP, SLIT and NTRK like family member 6
External IDs	OMIM: 609681 MGI: 2443198 HomoloGene: 12986 GeneCards: SLITRK6
Gene location ( Human)
Chr.	Chromosome 13 (human)
End	85,806,683 bp
Gene location ( Mouse)
Chr.	Chromosome 14 (mouse)
End	110,992,581 bp
RNA expression pattern
	Top expressed in
	bronchial epithelial cell; ; urethra; ; urinary bladder; ; trachea; ; minor salivary glands; ; jejunal mucosa; ; palpebral conjunctiva; ; rectum; ; duodenum; ; pancreatic epithelial cell;
	Top expressed in
	otolith organ; ; utricle; ; maxillary prominence; ; medial dorsal nucleus; ; islet of Langerhans; ; hand; ; midgut; ; mammillary body; ; nasal cavity; ; abdominal wall;
	More reference expression data
	; ;
	More reference expression data
Orthologs
	84189
	239250
	ENSG00000184564
	ENSMUSG00000045871
	Q9H5Y7
	Q8C110
	NM_032229
	NM_175499
	NP_115605
	NP_780708
	Wikidata
View/Edit Human	View/Edit Mouse

SLIT and NTRK-like protein 6 is a protein that in humans is encoded by the SLITRK6 gene.^[5]^[6]

Function

Members of the SLITRK family, such as SLITRK6, are integral membrane proteins with 2 N-terminal leucine-rich repeat (LRR) domains similar to those of SLIT proteins (see SLIT1). Most SLITRKs, including SLITRK6, also have C-terminal regions that share homology with neurotrophin receptors (see NTRK1). SLITRKs are expressed predominantly in neural tissues and have neurite-modulating activity.^[5]^[6]

Clinical significance

Mutations in SLITRK6 cause high myopia and deafness in humans and mice.^[7]

As a drug target

The protein is the target for the antibody-drug conjugate ASG-15ME which is in phase 1 clinical trials for urothelial cancer.^[8]

References

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000184564 – Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000045871 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ ^a ^b Aruga J, Yokota N, Mikoshiba K (Oct 2003). "Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue". Gene. 315: 87–94. doi: 10.1016/S0378-1119(03)00715-7. PMID 14557068.
^ ^a ^b "Entrez Gene: SLITRK6 SLIT and NTRK-like family, member 6".
^ Tekin M, Chioza BA, Matsumoto Y, Diaz-Horta O, Cross HE, Duman D, Kokotas H, Moore-Barton HL, Sakoori K, Ota M, Odaka YS, Foster J, Cengiz FB, Tokgoz-Yilmaz S, Tekeli O, Grigoriadou M, Petersen MB, Sreekantan-Nair A, Gurtz K, Xia XJ, Pandya A, Patton MA, Young JI, Aruga J, Crosby AH (2013). "SLITRK6 mutations cause myopia and deafness in humans and mice". J. Clin. Invest. 123 (5): 2094–102. doi: 10.1172/JCI65853. PMC 3635725. PMID 23543054.
^ Seattle Genetics and Agensys, an Affiliate of Astellas (October 2016). "Interim Analysis of a Phase 1 Dose Escalation Trial of ASG-22CE (ASG-22ME; enfortumab vedotin), an Antibody-Drug Conjugate (ADC) in Patients with Metastatic Urothelial Cancer". Poster Abstract #788P, European Society for Medical Oncology (ESMO) Congress, Copenhagen.

Hartley JL, Temple GF, Brasch MA (2001). "DNA Cloning Using In Vitro Site-Specific Recombination". Genome Res. 10 (11): 1788–95. doi: 10.1101/gr.143000. PMC 310948. PMID 11076863.
Wiemann S, Weil B, Wellenreuther R, Gassenhuber J, Glassl S, Ansorge W, Böcher M, Blöcker H, Bauersachs S, Blum H, Lauber J, Düsterhöft A, Beyer A, Köhrer K, Strack N, Mewes HW, Ottenwälder B, Obermaier B, Tampe J, Heubner D, Wambutt R, Korn B, Klein M, Poustka A (2001). "Toward a Catalog of Human Genes and Proteins: Sequencing and Analysis of 500 Novel Complete Protein Coding Human cDNAs". Genome Res. 11 (3): 422–35. doi: 10.1101/gr.GR1547R. PMC 311072. PMID 11230166.
Wiemann S, Arlt D, Huber W, Wellenreuther R, Schleeger S, Mehrle A, Bechtel S, Sauermann M, Korf U, Pepperkok R, Sültmann H, Poustka A (2004). "From ORFeome to Biology: A Functional Genomics Pipeline". Genome Res. 14 (10B): 2136–44. doi: 10.1101/gr.2576704. PMC 528930. PMID 15489336.
Mehrle A, Rosenfelder H, Schupp I, del Val C, Arlt D, Hahne F, Bechtel S, Simpson J, Hofmann O, Hide W, Glatting KH, Huber W, Pepperkok R, Poustka A, Wiemann S (2006). "The LIFEdb database in 2006". Nucleic Acids Res. 34 (Database issue): D415–8. doi: 10.1093/nar/gkj139. PMC 1347501. PMID 16381901.

This article on a gene on human chromosome 13 is a stub. You can help Wikipedia by expanding it.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000184564 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000045871 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[Aruga_2003-5] Aruga J, Yokota N, Mikoshiba K (Oct 2003). "Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue". Gene. 315: 87–94. doi: 10.1016/S0378-1119(03)00715-7. PMID 14557068.

[entrez-6] "Entrez Gene: SLITRK6 SLIT and NTRK-like family, member 6".

[pmid23543054-7] Tekin M, Chioza BA, Matsumoto Y, Diaz-Horta O, Cross HE, Duman D, Kokotas H, Moore-Barton HL, Sakoori K, Ota M, Odaka YS, Foster J, Cengiz FB, Tokgoz-Yilmaz S, Tekeli O, Grigoriadou M, Petersen MB, Sreekantan-Nair A, Gurtz K, Xia XJ, Pandya A, Patton MA, Young JI, Aruga J, Crosby AH (2013). "SLITRK6 mutations cause myopia and deafness in humans and mice". J. Clin. Invest. 123 (5): 2094–102. doi: 10.1172/JCI65853. PMC 3635725. PMID 23543054.

[Ph1-8] Seattle Genetics and Agensys, an Affiliate of Astellas (October 2016). "Interim Analysis of a Phase 1 Dose Escalation Trial of ASG-22CE (ASG-22ME; enfortumab vedotin), an Antibody-Drug Conjugate (ADC) in Patients with Metastatic Urothelial Cancer". Poster Abstract #788P, European Society for Medical Oncology (ESMO) Congress, Copenhagen.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

Function

Clinical significance

As a drug target

References

Further reading